INEGY 10 MG80 MG TABLETS

Country: ইস্রায়েল

ভাষা: ইংরেজি

সূত্র: Ministry of Health

সক্রিয় উপাদান:

EZETIMIBE; SIMVASTATIN

থেকে পাওয়া:

MERCK SHARP & DOHME ISRAEL LTD

এটিসি কোড:

C10AA01

ফার্মাসিউটিকাল ফর্ম:

TABLETS

রচনা:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

প্রশাসন রুট:

PER OS

প্রেসক্রিপশন টাইপ:

Required

Manufactured by:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Therapeutic group:

SIMVASTATIN

Therapeutic area:

SIMVASTATIN

থেরাপিউটিক ইঙ্গিত:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

অনুমোদন তারিখ:

2012-04-30